Pharma Commercialisation Services Update – February 2022
We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector. For some time, Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research.
This report focuses on commercialisation, encompassing Healthcare Marketing, Market Access and Medical Affairs; the least consolidated of the three, but arguably the most exciting from a mid-market M&A perspective.
We hope that you enjoy this report and look forward to discussing the data and underlying themes with you. Do get in touch!Click to read Pharma Commercialisation Services Update: February 2022